Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. [electronic resource]
Producer: 20060324Description: 1447-55 p. digitalISSN:- 0022-1767
- Animals
- Antigen Presentation -- immunology
- CD4-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- administration & dosage
- Cell Communication -- immunology
- Cells, Cultured
- Dendritic Cells -- immunology
- Epitopes, T-Lymphocyte -- immunology
- Female
- Histocompatibility Antigens Class I -- immunology
- Histocompatibility Antigens Class II -- administration & dosage
- Lymphocyte Activation -- immunology
- Lymphoma, B-Cell -- immunology
- Male
- Melanoma, Experimental -- immunology
- Mice
- Mice, Inbred A
- Mice, Inbred BALB C
- Mice, Inbred C3H
- Mice, Transgenic
- Necrosis
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.